Home/ Stocks/ YARW

Yarrow Bioscience, Inc. Common Stock

YARW XNAS

$15.60 +2.00 (+14.71%) ▲ 15-min delayed

Open

$13.80

High

$15.94

Low

$13.62

Volume

229.8K

Market Cap

$131.65M

About Yarrow Bioscience, Inc. Common Stock

Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.

Sector: PHARMACEUTICAL PREPARATIONS Website →

Related Market News

No specific coverage for YARW yet. Check out our latest market news or earnings calendar.

Get YARW Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Yarrow Bioscience, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.